TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Laurantis Pharma Oy
Closing information (x1000 NOK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
19
|
9 | |
Financial expenses |
345
|
38,370
|
887 |
Earnings before taxes |
-5,624
|
-61,780
|
-15,111 |
Total assets |
2,590
|
803
|
52,716 |
Current assets |
2,435
|
640
|
679 |
Current liabilities |
1,554
|
1,835
|
1,466 |
Equity capital |
-33,665
|
-29,509
|
30,547 |
- share capital |
27
|
29
|
27 |
Employees (average) | 1 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
-1299.8%
|
-3674.8%
|
57.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
-325157.9%
|
-167900% | |
Return on assets (ROA) |
-203.8%
|
-2915.3%
|
-27.0% |
Current ratio |
156.7%
|
34.9%
|
46.3% |
Return on equity (ROE) |
16.7%
|
209.4%
|
-49.5% |
Change turnover |
10
|
9 | |
Change turnover % | 100% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.